Search Results - "LE DU, Damien"
-
1
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis
Published in The European respiratory journal (01-03-2017)“…Bedaquiline, a recently approved drug for the treatment of multidrug-resistant tuberculosis (MDR-TB), is recommended for a duration of 24 weeks. There are…”
Get full text
Journal Article -
2
Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia
Published in The European respiratory journal (01-03-2018)“…Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) represent a therapeutic challenge [1]. Two anti-TB agents, bedaquiline and…”
Get full text
Journal Article -
3
-
4
Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014
Published in Emerging infectious diseases (01-03-2016)“…We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most…”
Get full text
Journal Article -
5
Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures
Published in The Journal of infection (01-02-2017)“…Highlights 3-5 bullet points (84 words) • Discontinuing isolation measures for tuberculosis patients under treatment relies mainly on the infectiousness of…”
Get full text
Journal Article -
6
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
Published in The European respiratory journal (01-07-2020)“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has attracted interest because of its global rapid spread,…”
Get full text
Journal Article -
7
Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort
Published in Clinical infectious diseases (15-01-2015)“…Background. Bedaquiline is a new antibiotic that was approved for the treatment of multidrug-resistant (MDR) tuberculosis. We aimed to evaluate the short-term…”
Get full text
Journal Article -
8
Bedaquiline plus delamanid for XDR tuberculosis
Published in The Lancet infectious diseases (01-03-2016)“…The combination was initiated in a patient in whom an effective treatment cannot be designed, in the consideration that its potential life-saving benefits…”
Get full text
Journal Article -
9
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors
Published in The European respiratory journal (01-03-2017)“…Bedaquiline (BDQ) has demonstrated potent clinical activity against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis…”
Get full text
Journal Article -
10
Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment
Published in Clinical infectious diseases (08-02-2023)“…Abstract Background Treatment of multidrug-resistant (MDR) tuberculosis with linezolid is characterized by high rates of adverse events. Evidence on…”
Get full text
Journal Article -
11
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
Published in The European respiratory journal (01-08-2016)“…Bedaquiline (Bdq) is approved for the treatment of multidrug-resistant (MDR) tuberculosis (TB). In a phase IIb trial, Bdq allowed a significant reduction in…”
Get full text
Journal Article -
12
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study
Published in The Journal of infection (01-06-2022)“…ObjectivesLimited evidence is available on the co-administration of treatment for hepatitis C virus (HCV) and multidrug-resistant tuberculosis (MDR-TB). The…”
Get full text
Journal Article -
13
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial
Published in Journal of antimicrobial chemotherapy (01-03-2018)“…Intermittent treatment could improve the convenience, tolerability and cost of ART, as well as patients' quality of life. We conducted a 48 week multicentre…”
Get full text
Journal Article -
14
Meningitis and Endocarditis Caused by Campylobacter fetus after Raw-Liver Ingestion
Published in Journal of Clinical Microbiology (01-09-2013)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
15
Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study
Published in Journal of antimicrobial chemotherapy (11-02-2021)“…Abstract Objectives Despite the effectiveness of antiretroviral (ARV) therapy to control HIV infection, HIV-associated neurocognitive disorders (HAND) remain…”
Get full text
Journal Article -
16
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons not to repeat past errors
Published in The European respiratory journal (2017)“…Bedaquiline (BDQ) has demonstrated potent clinical activity against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis…”
Get full text
Journal Article -
17
Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment
Published in Clinical infectious diseases (19-06-2022)“…Abstract Background Treatment of multidrug-resistant (MDR) tuberculosis with linezolid is characterized by high rates of adverse events. Evidence on…”
Get full text
Journal Article -
18
Meningoencephalitis Due to HIV Replication Despite Plasmatic Viral Control
Published in Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) (01-11-2011)“…We report a symptomatic case of HIV replication in CSF (Cerebro Spinal Fluid) despite low plasmatic viral load. The patient, known HIV positive since 3 years,…”
Get full text
Journal Article -
19
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium
Published in The international journal of tuberculosis and lung disease (01-10-2019)“…SETTING: The World Health Organization (WHO) recommends that multidrug-resistant tuberculosis (MDR-TB) treatment should be managed in collaboration with…”
Get full text
Journal Article -
20